Ancora Advisors, LLC Athersys, Inc Transaction History

Ancora Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $24 - $42	-40 Reduced 1.96%	2,000 $1,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.06 $24 - $42	40 Added 2.0%	2,040 $4,000
Q2 2021 Aug 13, 2021	SELL	$1.41 - $1.94 $56 - $77	-40 Reduced 1.96%	2,000 $3,000
Q1 2021 May 14, 2021	BUY	$1.61 - $2.77 $64 - $110	40 Added 2.0%	2,040 $4,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $3,940 - $7,960	2,000 New	2,000 $6,000
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.65 $62,920 - $85,800	-52,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$1.39 - $1.71 $12,510 - $15,390	9,000 Added 20.93%	52,000 $78,000
Q2 2018 Aug 10, 2018	BUY	$1.76 - $2.79 $1,760 - $2,790	1,000 Added 2.38%	43,000 $85,000
Q1 2018 May 15, 2018	SELL	$1.34 - $2.03 $8,040 - $12,179	-6,000 Reduced 12.5%	42,000 $77,000
Q3 2017 Nov 14, 2017	BUY	$1.5 - $2.55 $72,000 - $122,399	48,000	48,000 $99,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.